Showing 1 - 7 results of 7 for search 'Emilio Fernández-Espejo', query time: 0.03s Refine Results
  1. 1
    Psychostimulant Drugs and Neuroplasticity

    Psychostimulant Drugs and Neuroplasticity by Emilio Fernandez-Espejo, Nieves Rodriguez-Espinosa

    Published 2011-06-01
    Get full text
    Article
  2. 2
    Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model

    Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model by Fadwa El Banoua, Isabel Caraballo, Juan A Flores, Beatriz Galan-Rodriguez, Emilio Fernandez-Espejo

    Published 2004-07-01
    Get full text
    Article
  3. 3
    Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease

    Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease by Emilio Fernández-Espejo, Fernando Rodríguez de Fonseca, Ana Luisa Gavito, Antonio Córdoba-Fernández, José Chacón, Ángel Martín de Pablos

    Published 2022-05-01
    Get full text
    Article
  4. 4
    A Rare Paronychia with Superinfection with <i>Prevotella bivia</i> and <i>Staphylococcus haemolyticus</i>: The Importance of Early Microbiological Diagnosis

    A Rare Paronychia with Superinfection with <i>Prevotella bivia</i> and <i>Staphylococcus haemolyticus</i>: The Importance of Early Microbiological Diagnosis by Jessica Grande-Del-Arco, María Dolores Jimenez-Cristino, Raquel García-de-la-Peña, Emilio Fernández-Espejo, Antonio Córdoba-Fernández

    Published 2020-11-01
    Get full text
    Article
  5. 5
    Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease

    Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease by Emilio Fernández-Espejo, Fernando Rodríguez de Fonseca, Juan Suárez, Eduardo Tolosa, Dolores Vilas, Iban Aldecoa, Joan Berenguer, Fátima Damas-Hermoso

    Published 2021-05-01
    Get full text
    Article
  6. 6
    Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

    Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism by Emilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, Fadwa El Banoua, Belen Ferrer, Juan A. Flores, Beatriz Galan-Rodriguez

    Published 2005-04-01
    Get full text
    Article
  7. 7
    Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease

    Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease by Emilio Fernández-Espejo, Ana L. Gavito, Juan Suárez, Eduardo Tolosa, Dolores Vilas, Iban Aldecoa, Joan Berenguer, Antonio Córdoba-Fernández, Fátima Damas-Hermoso, Fernando Rodríguez de Fonseca

    Published 2022-01-01
    Get full text
    Article

Search Tools: